- Condition: Factory New
- Weight: 1.34 lb
- Test Kit, CLIA-Waived, 10 tests/kt (Continental US Only - including Alaska & Hawaii)
-
Learn more:
- MFR: Quidel Corporation Ships from MFI Medical
- MPN: 20324
- Phone: (858) 552-1100
Frequently asked questions
Is this rapid diagnostic test accurate?
Yes, the Quidel QuickVue Adenoviral Conjunctivitis Test is engineered as a fast, accurate diagnostic platform intended for rapid results at the point of care.
Its capability for quick, reliable identification provides several key benefits for patient care and management:
- Timely Isolation: Enables the prompt identification and isolation of contagious patients.
- Antibiotic Stewardship: Supports appropriate prescribing by quickly confirming a viral etiology, which helps reduce the unnecessary use of antibiotics for non-bacterial infections.
Furthermore, its CLIA-Waived status ensures it can be easily implemented and run in various clinical settings, such as urgent care centers or physician offices.
Is the Quidel Quickvue Adenoviral Conjunctivitis Test CLIA-waived?
Yes, the Quidel Quickvue Adenoviral Conjunctivitis Test is CLIA-waived, simplifying the testing process for various healthcare settings.
How does this test help in antibiotic stewardship?
This test helps reduce the inappropriate use of antibiotics by accurately identifying viral infections, enabling clinicians to differentiate between viral and bacterial conjunctivitis.
What is the quantity of tests included in each kit?
Each Quidel Quickvue Adenoviral Conjunctivitis Test kit contains 10 tests.
Where is the Quidel Quickvue Adenoviral Conjunctivitis Test available for distribution?
The Quidel Quickvue Adenoviral Conjunctivitis Test is available for distribution within the Continental US, including Alaska and Hawaii.
What is the intended use of this test?
The Quidel QuickVue Adenoviral Conjunctivitis Test is designed to identify adenoviral conjunctivitis, indicating it is used to test for infections of the eye’s conjunctiva.
Who manufactures the Quidel Quickvue Adenoviral Conjunctivitis Test?
The Quidel Quickvue Adenoviral Conjunctivitis Test is manufactured by Quidel Corporation.
What is the intended use of the Quidel QuickVue Adenoviral Conjunctivitis Test?
The Quidel QuickVue Adenoviral Conjunctivitis Test is designed for the rapid identification of adenoviral conjunctivitis. It helps clinicians accurately diagnose the condition, allowing for better management of contagious patients and promoting responsible antibiotic use by reducing unnecessary prescriptions.
Does this test provide rapid, accurate results?
Yes, the Quidel QuickVue Adenoviral Conjunctivitis Test is a fast, disposable diagnostic platform designed for the rapid and accurate identification of adenoviral conjunctivitis. This speed is crucial for clinical decision-making and patient management, allowing providers to:
- Quickly Isolate and Manage: Promptly implement isolation and management protocols for contagious patients.
- Support Antibiotic Stewardship: Immediately differentiate viral infections from bacterial ones, which helps prevent the inappropriate prescribing of antibiotics.
Furthermore, the test is CLIA-Waived, ensuring its applicability and ease of use in a variety of point-of-care settings.
How does it help manage contagious patients?
This test is specifically designed to help identify, isolate, and manage contagious patients with adenoviral conjunctivitis, which is crucial for infection control in clinical settings.